The experts in executive compensation consulting.

Pay Governance LLC is an independent firm that serves as a trusted advisor on executive compensation matters to board and compensation committees. Our work helps to ensure that our clients' executive rewards programs are strongly aligned with performance and supportive of appropriate corporate governance practices. We work with over 450 companies annually, are a team of nearly 75 professionals in the U.S. with affiliates in Europe and Asia with experience in a wide array of industries, company life cycles and special situations.

Find out how we work

Current Issues in Executive Compensation

Pay Governance understands that times remain uncertain. Our domain expertise remains executive compensation consulting. Therefore, each week we will continue to provide you with a short newsletter to keep you abreast of developments in the executive remuneration world.

Get that Newsletter here

Featured Viewpoints

Record Low ISS S&P 500 Say on Pay Opposition: The Trends Behind the Decline

In our prior Viewpoint, “Recap of the 2024 Say on Pay Season,” 1 we reported that Institutional Shareholder Services (ISS) opposed 7.7% of S&P 500 Say on Pay (SOP) proposals, an unprecedented low. Prior to 2024, ISS opposed about 11% of S&P 500 SOP proposals, on average, each year. In this Viewpoint, the second of our 2024 SOP series, we explore the trends that may have led ISS to recommend against SOP at a historically low rate.

Through careful review of the S&P 500 companies that received 2024 ISS SOP opposition as of August 31, 2024,2 we identified two areas of improvement compared to 2022 and 2023. These changes likely contributed to the overall reduction in 2024 ISS against SOP recommendations.

  1. Significantly better performance on the ISS Multiple of Median (MOM) test. The MOM test evaluates the ratio of 1-year CEO pay to the median CEO pay of the ISS-selected peer group and has historically been (and continues to be) a meaningful predictor of adverse ISS SOP recommendations. The average MOM outcome was 1.7x in 2024, compared to 2.2x in 2023 and 2.4x in 2022, demonstrating a migration of CEO pay toward peer median levels and fewer outlying pay packages.
  2. Improvement in Compensation Committee responsiveness to proxy advisor and shareholder concerns over executive pay. We observed fewer Compensation Committees being criticized by ISS for poor responsiveness to shareholder concerns and fewer cases of significant one-time awards that led to an against SOP recommendation. In addition, the number of companies that received ISS opposition to SOP in two consecutive years declined, demonstrating that companies are getting better at addressing investor feedback.

We discuss each area of improvement in detail below.

1. Significantly Better MOM Performance

The three primary ISS quantitative pay for performance (P4P) tests are the Relative Degree of Alignment (RDA) test, the MOM test, and the Pay-TSR Alignment (PTA) test. We examined the distribution of concern levels on each of these three quantitative P4P tests for the companies that received ISS SOP opposition. According to ISS, “Low concern generally indicates long-term alignment between CEO pay and company performance. A Medium concern indicates a moderate misalignment and a High concern indicates a more severe misalignment.” 3

The ISS quantitative P4P tests are highly predictive of ISS SOP recommendations. There is a greater likelihood of ISS SOP opposition when receiving an overall concern level of “High” or “Medium.” In 2024, 71% of the companies that received SOP opposition from ISS scored an overall concern level of “High” or “Medium” on the quantitative P4P assessment. This is similar to the number of companies opposed by ISS that had elevated P4P concern levels in both 2023 (77% of companies) and 2022 (75% of companies).

When we examined the individual primary quantitative P4P test outcomes from 2022 to 2024, different patterns emerged. Among companies that received ISS SOP opposition, we observed the greatest improvement in the MOM results. We also observed improvement in PTA results, but most companies continued to receive a “Low” concern. Outcomes of the RDA fluctuated between 2022 and 2024 but generally did not improve. Our conclusions for each of the P4P tests are as follows:

  • RDA: measures alignment of 3-year relative CEO pay and 3-year relative TSR. Half of all S&P 500 companies that received SOP opposition from ISS scored a “High” or “Medium” concern on the RDA, showing that RDA outcomes continue to be a primary determining factor of SOP recommendations.
  • MOM:evaluates the ratio of 1-year CEO pay to ISS peer median CEO pay.In 2024, only 21% of S&P 500 companies receiving an against SOP recommendation received an elevated concern under the MOM test (an elevated concern is assigned for MOMs that are above 1.69x). This starkly contrasts with 2022 and 2023 results, in which nearly half of all companies opposed by ISS scored an elevated concern on the MOM. Examined another way, the average MOM ratio was 1.7x in 2024, compared to 2.2x in 2023 and 2.4x in 2022. This suggests that CEO pay for FY23 has migrated closer to the median of ISS peers for most companies that were opposed by ISS. In recent years, the MOM test has become increasingly predictive of ISS SOP recommendations. Thus, as companies have shifted their CEO pay quantum towards the “safe middle,” there have been fewer against SOP recommendations overall.
  • PTA: measures the absolute alignment of 5-year CEO pay and 5-year indexed TSR. In 2024, nearly all companies (94%) that received SOP opposition from ISS had a “Low” concern on the PTA test. This is an improvement over 2023 and 2022 levels (72% and 81%, respectively) but illustrates a consistent trend that PTA outcomes are not a key driver of SOP recommendations.

2. Improvement in Compensation Committee Responsiveness

In determining its SOP recommendations, in addition to the quantitative P4P tests, ISS conducts a qualitative assessment of executive compensation programs and practices. We compared the qualitative assessments cited in the ISS against SOP recommendations for 2022 through 2024 across six categories. Our objective was to determine if there were significant improvements in the categories over the three years that could have contributed to the decline in adverse SOP recommendations.

The largest improvements observed in the qualitative reasons for ISS opposition of S&P 500 SOP proposals between 2023 and 2024 were (1) better Compensation Committee responsiveness and (2) fewer sizable one-time/special awards.

  1. Improved Compensation Committee Responsiveness:Both the percentage and number of companies in 2024 that received ISS SOP opposition primarily due to poor Compensation Committee responsiveness decreased compared to 2023 and 2022 levels. The sustained decline suggests companies continued to take active measures to directly engage with major investors to address their concerns following a SOP proposal that received low support the prior year.
  2. Reduction in Sizeable One-Time/Special Awards:There was a decrease in the percentage and number of companies that received adverse ISS SOP recommendations due primarily to the grant of special or one-time awards. The practice of granting one-time awards is now strongly disfavored by both proxy advisors and institutional investors. The decline in the use of such awards is consistent with our observation of companies being increasingly responsive to investor and proxy advisor preferences. In addition, the reduction in the use of one-time awards may have contributed to the decrease in “High” and “Medium” concern levels for the MOM test in 2024 — the P4P test focused on 1-year CEO pay quantum.

As another way to evaluate the level of Compensation Committee responsiveness to poor SOP outcomes, we examined the prevalence of consecutive ISS against SOP recommendations. In the 2024 SOP season, the number of companies receiving repeat ISS SOP opposition in two consecutive years (i.e., against in both 2023 and 2024) is tracking below historical levels. The 2022 SOP season featured a historically high 24 companies with against recommendations in consecutive years (or 40% of the total companies opposed by ISS in 2022). The roster of consecutive against recommendations declined significantly in the 2023 SOP season to 13 companies and has further decreased to 9 companies so far in the 2024 SOP season.

As originally observed in 2023, the continued decline in companies with consecutive ISS SOP opposition demonstrates increased mindfulness of proxy advisor and investor preferences and a willingness to address shareholders’ concerns.

Conclusion

In the 2024 SOP season, we observed a notable decline in ISS opposition of S&P 500 SOP proposals. Based on our review, the main catalysts of the decrease in ISS opposition appear to be (1) improved performance on the MOM quantitative test as CEO pay quantum shifted toward the “safe middle” and (2) continued growth in Compensation Committee responsiveness to proxy advisor and shareholder preferences. In our next Viewpoint in our 2024 SOP series, we will dive into how S&P 500 companies demonstrated responsiveness by examining the actions taken after receiving ISS SOP opposition.

General questions about this Viewpoint can be directed to Linda Pappas (linda.pappas@paygovernance.com).

_____________________

1.Perla Cuevas, José Lawani, Linda Pappas, and Olivia Wright. Recap of the 2024 Say on Pay Season. Pay Governance. August 29, 2024. https://www.paygovernance.com/viewpoints/recap-of-the-2024-say-on-pay-season
2.Reflect ISS SOP vote recommendations available through August 31, 2024, collected from ISS Corporate’s Voting Analytics database.
3.Institutional Shareholder Services. United States, Pay-for-Performance Mechanics, ISS’ Quantitative and Qualitative Approach. December 8, 2023. https://www.issgovernance.com/file/policy/active/americas/Pay-for-Performance-Mechanics.pdf?v=2

Read More

Featured Viewpoint

Recap of the 2024 Say on Pay Season

Pay Governance has compiled information on Say on Pay (SOP) outcomes and related total shareholder returns (TSR) for S&P 500 companies since the dawn of the SOP era, which dates to the 2011 proxy season. Based on our analysis of these data, this article places into context the recent results of the 2024 SOP season compared to historical trends. We find that companies have had greater success in the current SOP season, with ISS opposition to SOP proposals and the number of companies failing SOP at record lows.

Background: Say on Pay 2011-2024

Figures 1-3 below include the history of S&P 500 company SOP outcomes beginning in 2011 through July 31, 2024.

Figure 1: Unfavorable S&P 500 SOP Proposals by Year1

As of July 31, 2024, our analysis of the current SOP season reveals a significant decrease in the number of failed proposals among S&P 500 companies. The failure rate of 0.9% is trending towards the low rates last observed in 2015 and 2016. After reaching a peak of 22 failed proposals in 2022, the number of failed proposals dropped to 13 in 2023 and has further declined to just 4 so far in 2024 (equal to the all-time low observed in 2015). The current decline in failed SOP proposals may be attributed to improved 1- and 3-year TSR performance, company attention to shareholder feedback on executive pay programs, and positive shareholder sentiment towards the market in general.

Additionally, the percentage of SOP proposals receiving ISS opposition in 2024 year-to-date reached a historic low (7.7%) following a recent uptick in 2022 (12.5%) and a return to “normalcy” in 2023 (9.5%). The decline in ISS “against” SOP recommendations is also likely contributing to the decline in failed SOP proposals in 2024. This said, we will continue to monitor SOP outcomes through the end of the proxy season.

Figure 2: S&P 500 Historical 1-Year TSR 1 & SOP Outcomes 1

Figure 3: S&P 500 Historical 3-Year TSR 1 & SOP Outcomes 1

Findings from our previous Viewpoint titled, “The 2023 Say on Pay Season – Outcomes and Observations,” 3 showed that the 2022 and 2023 SOP seasons ran counter to the premise that TSR performance should be correlated with SOP proposal success. Although TSR performance was strong for the period ending in 2021
(1- and 3-year TSR of +27% and +24%, respectively), the number of failed SOP proposals in 2022 spiked to 22. Failed SOP proposals in 2023 unexpectedly decreased to 13 when TSR performance declined relative to the prior period (1- and 3-year TSR ending in 2022 was -19% and +6%, respectively).

However, for 2024 the linkage of TSR performance to SOP proposal success holds true. For the period ending in 2023, 1- and 3-year TSR results (+24% and +8%, respectively) improved over the prior period and failed SOP proposals dipped to just 4 companies.

Glass Lewis SOP Recommendations

With the unprecedented decline in failed SOP proposals and reduced ISS opposition to SOP proposals observed in the current season, we also reviewed Glass Lewis SOP vote recommendations to assess if a similar trend would be identified.

As expected, Glass Lewis 2024 SOP recommendations (12%) are tracking below 2023 levels (17%). However, an anomaly was observed during 2023 when Glass Lewis opposed SOP proposals at a higher rate than recent history. Unlike ISS, the spike in Glass Lewis “against” recommendations in 2023 tracks with relatively worse TSR performance during the corresponding period.

Prior to 2023, the Glass Lewis SOP “against” rate consistently ranged from 12% to 14%. Given that the Glass Lewis 2024 opposition rate of 12% tracks with historical levels, it appears that Glass Lewis’s recommendations are not particularly correlated to the decline in failed SOP proposals in 2024.

Figure 4: S&P 500 1- and 3-Year TSR 1 & Proxy Advisor “Against” SOP Recommendations 1 ,4

Conclusion

There is a notable decline in the number of failed S&P 500 SOP proposals in 2024. This may be associated with improvement in TSR performance compared to the prior period, company responsiveness to shareholder feedback, and the decline in ISS opposition likely resulting from the prior two factors. Given that the Glass Lewis opposition rate in 2024 is similar to historical levels, Glass Lewis’s recommendations appear to be less correlated to S&P 500 company SOP success this year. We are continuing to monitor the rate of failed SOP proposals through the remainder of 2024 and in future years to determine if this year’s trends are part of a new normal of increased shareholder satisfaction with executive pay programs or an aberration that will reverse course.

General questions about this Viewpoint can be directed to Linda Pappas (linda.pappas@paygovernance.com).

_________________________

1 TSR data for the S&P 500 were collected from S&P’s Capital IQ database.
2 ISS vote recommendations and SOP vote outcomes were collected from ISS Corporate’s Voting Analytics database.
3 Perla Cuevas, Jose Lawani, Joe Mallin, and Linda Pappas. The 2023 Say on Pay Season – Outcomes and Observations. Pay Governance. September 14, 2023. https://www.paygovernance.com/viewpoints/the-2023-say-on-pay-season-outcomes-and-observations.
4 Glass Lewis vote recommendations were collected from the Diligent Market Intelligence database.

Featured Viewpoint

Relative TSR Awards: Challenges and Trade-Offs Using Stock Price vs. Monte Carlo Calibration Methods

Introduction

Thousands of companies, including more than 70% of the S&P 500 companies, grant performance stock units (PSUs) with relative total shareholder return (TSR) or stock price performance-vesting conditions. These incentives can be very motivational, help align management rewards with shareholder returns, and are strongly favored by some investors and proxy advisors. Nevertheless, differing perspectives on the value of these awards, affecting the sizing of grants, may impact the motivational power of these grants.

Companies granting relative TSR-PSUs are faced with the dilemma of how to determine the number of shares being granted. This question comes up often as compensation committees and/or management wonder if the grant date value being delivered is aligned with the intended grant value. Choosing market stock price (either as of the grant date or average toward the grant date) or a Monte Carlo valuation to determine the number of shares being granted can be more complex than one would think, given each calibration approach typically results in a different number of shares. This Viewpoint is intended to help inform companies of the various trade-offs, and it can be used as a general guide to help companies decide which approach makes the most sense for their circumstances.

The Case for Relative TSR Plans

The increasing prevalence of relative TSR performance metrics in performance-based equity awards is driven by multiple factors, with a principal factor being the preferences of major institutional investors and proxy advisors when evaluating alignment between executive pay and performance. For example, Vanguard considers a company’s “three-year total shareholder return and realized pay over the same period vs. a relevant set of peer companies” for evidence of pay and performance alignment. [1] Both Institutional Shareholder Services (ISS) and Glass Lewis use various relative financial and/or TSR performance metrics in their pay-for-performance evaluations to support their recommendations to companies’ say-on-pay proposals. In this context, many companies perceive TSR awards as a means to simultaneously align their compensation with an investors' perspective on performance and conform to known pay-for-performance evaluation frameworks. Further, the introduction of TSR awards has also become a common action taken in response to unfavorable say-on-pay results.

From the Board’s perspective, TSR plans can create strong alignment with shareholder interests while mitigating challenges with setting multi-year financial or operational goals (particularly within volatile industry sectors) or achieving “apples-to-apples” relative performance comparisons among peers arising from differences in the timing and comparability of reporting.

These factors have contributed to making relative TSR the most prevalent relative performance metric companies use to determine PSU award payouts. TSR is often used as a standalone weighted performance metric but may also be used as a payout modifier. Most often, the subject company’s TSR performance is compared to constituents of a general stock index (e.g., S&P 500), an industry specific stock index, or a custom TSR performance peer group selected by the company.

Valuation and Disclosure of TSR and Other Market-Conditioned Awards

Central to the question of the calibration and motivational effect of TSR awards is their valuation. These valuations — and ultimately the proxy-reported values of these awards — are dictated by accounting guidance, which treats awards subject to market conditions (e.g., TSR, stock price) fundamentally differently from those tied to absolute financial and operational metrics.

For restricted shares, or performance shares subject to financial or operational metrics, the valuation of these awards is generally equal to the stock price on the grant date. Other aspects of the design, including the performance measurement period and minimum/maximum award payout opportunities generally have no bearing on the valuation of the award. Assuming a $10 stock price, in this case all awards and plan variations are valued equally. If you make the goal harder/easier: $10. If you increase/decrease the payout opportunity: $10. If you shorten/lengthen the performance period: $10. As a result, there is little friction when revising incentive designs or shifting between restricted stock and PSUs.

By comparison, the valuation of awards subject to market conditions must consider the effect of those conditions when determining the award value for accounting/disclosure purposes, which is often accomplished using a Monte Carlo valuation methodology. In contrast with financial/operational PSU awards which are valued based on the grant date stock price, market-conditioned awards are valued based on their expected payout value. This results in valuations which are often higher than the stock price on the date of grant (e.g., $12 valuation relative to $10 grant date stock price).[2] Importantly, as plan provisions change, so may the valuation. If you make the goal easier or increase the payout opportunity, the valuation may increase (e.g., $13). Conversely, if you make the goals harder, or reduce the payout opportunities, the valuation may decrease (e.g., $11). This can significantly impact the proxy-reported value of these awards and may significantly change the motivational impact of awards when transitioning to/from market-conditioned awards.

Further, proxy advisors ISS and Glass Lewis both use grant date stock price for performance-based full-value stock awards (i.e., PSUs or performance stock awards). When measuring compensation and conducting quantitative pay-for-performance assessments:

  • ISS values all performance-based awards using the grant date stock price and the target payout opportunity . This results in parity between the valuation of PSUs with financial/operational metrics and market-based metrics (e.g., TSR). Under this framework, this may result in lower valuations for TSR awards than is reported by companies in their proxy statements.[3]
  • Glass Lewis uses the same approach as ISS when valuing performance-based stock awards.[4] In addition, Glass Lewis considers a measure of realized pay in their evaluations, which emphasizes the value of awards when earned rather than when granted (as is generally reflected in the proxy).

Tradeoffs When Calibrating Awards

Relative TSR PSUs are often granted to top executives, with a pre-determined $ target or intended $ grant value. Given differing views on the “value” of TSR awards, companies often debate the proper method to deliver as they seek to balance the views of award recipients with disclosure requirements and investor perspectives.

Our experience and research suggest market practice is roughly evenly split between those which convert target grant values to a number of PSU using either (i) the stock price approach or (ii) the accounting / Monte Carlo approach. The following exhibit illustrates the financial differences between these two approaches.

Exhibit I: Relative TSR PSU Conversion Illustrative Example

There are advantages and challenges in using each granting approach which should be considered based on each Company’s priorities, valuation objectives, and resources available. Below we summarize several of these key advantages and challenges.

Exhibit II: Relative TSR Awards Granting Approach Comparison Summary

Given the advantages and challenges of each granting approach, there is no singular or correct method. For companies that currently grant relative TSR PSUs, there may not be a compelling reason for change in the near term.

For companies considering adding relative TSR as a PSU performance metric, management and compensation committees should decide which conversion approach best suits the objectives of the Company.

For example, if a company emphasizes communication and value perception with PSU to participants, the stock price approach may be the preferred choice. This most likely will result in a higher proxy-reported value for the award than the value that may have been communicated to the participant as their intended target opportunity.

In contrast, if a company emphasizes consistency between the intended target opportunity and its accounting and proxy reported values, the Monte Carlo approach may be the preferred choice.

General questions about this Viewpoint can be sent to (ira.kay@paygovernance.com) or Ben Stradley (bentham.stradley@paygovernance.com).

___________________________

[1] From 2024 Vanguard Proxy Voting Policy for U.S. Portfolio Companies.
[2] Similarly, option valuation relies on expected payout value. For example, an option with the exercise price set at the current market price would have $0 intrinsic value at grant but still have a positive grant date value based on expected value in the future.
[3] For stock options, ISS also has a different approach than what most companies use to value their options. ISS uses a full-life / term approach and price volatility within a shorter period of time compared to an expected life approach and price volatility over a longer period adopted by most companies when calculating option value. This often results in a higher option value than what is reported by companies in proxy statements.
[4] Glass Lewis typically uses company disclosed values for options / stock appreciation rights, which differs from the ISS approach stated above.

Events

No items found.
No items found.
No items found.

Our Services

We are innovative thinkers with experience in the full range of executive compensation consulting services.

We simplify the complexities of the executive pay process. Our consultants are skilled at helping clients design and administer programs that appeal to reason, hold up under scrutiny, and successfully link executive pay to shareholder value.

View all services